Numerous studies have demonstrated the importance of Tregs in preclinical models of KRAS-mutant lung cancer as depletion of these immunosuppressive cells stimulates antitumor immunity and reduces tumor growth (35). This evidence concerns the gene KRAS and lung carcinoma.